No increased risk of hospitalization for heart failure for patients treated with dipeptidyl peptidase-4 inhibitors in Taiwan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

No increased risk of hospitalization for heart failure for patients treated with dipeptidyl peptidase-4 inhibitors in Taiwan

Published:2016-10 Issue: Volume:220 Page:14-20
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Chang Chia-Hsuin,Chang Yi-Cheng,Lin Jou-Wei,Caffrey James L.,Wu Li-Chiu,Lai Mei-Shu,Chuang Lee-Ming

Funder

Taiwan's Ministry of Science and Technology

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence;Ghali;Arch. Intern. Med.,1990

2. Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes;Reis;J. Am. Coll. Cardiol.,1997

3. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes;Nissen;N. Engl. J. Med.,2007

4. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial;Dormandy;Lancet,2005

5. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials;Lincoff;JAMA,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained-Release Vildagliptin 100 mg in Type 2 Diabetes Mellitus: A Review;Cureus;2023-05-18

2. Cardioprotective effects of dipeptidyl peptidase-4 inhibitors versus sulfonylureas in addition to metformin: A nationwide cohort study of patients with type 2 diabetes;Diabetes & Metabolism;2022-05

3. Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus;Diabetology & Metabolic Syndrome;2022-02-14

4. Targeting AGE‐RAGE signaling pathway by Saxagliptin prevents myocardial injury in isoproterenol challenged diabetic rats;Drug Development Research;2021-01-17

5. Comparison of Different Case-Crossover Variants in Handling Exposure-Time Trend or Persistent-User Bias: Using Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure as an Example;Value in Health;2020-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3